DevPro’s Colin Reisner Featured in ATS Philanthropy Campaign
DECEMBER 18, 2024 – DevPro Biopharma Co-Founder and CEO Colin Reisner is featured in a new video highlighting his involvement in the American Thoracic Society (ATS) Philanthropy Terrific Twenty campaign. Originally called the Terrific Ten, the circle of esteemed donors each committed to giving a minimum of $5,000 a year for five years. Due to overwhelming interest and support, the effort was expanded to the Terrific Twenty with a goal of increasing philanthropic donations to develop a large research endowment and further expand ATS education and lobbying activities.
GO HERE to view the new ATS Donor Spotlight video on YouTube.
With over 30 years of experience in internal medicine, allergy, and immunology, Colin has contributed to the development of numerous life-changing treatments now available on the market. In the new video, Colin shares his journey as a physician and his passion for helping people breathe easier. Alongside his wife Natasha, they joined the giving initiative to support ATS Philanthropy and make a meaningful difference for those suffering from respiratory disorders. Colin is an ATS Fellow, a distinction given to members who have made significant contributions to the fields of pulmonary, critical care, and/or sleep medicine.
ATS is a global community of health care providers and researchers that works to improve respiratory health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Philanthropic support helps fund research, provide education, and increase the impact on global health.
###
DevPro Biopharma
DevPro Biopharma LLC is a fully integrated, stand-alone clinical development company with the mission to design, develop, and deliver molecules into medicines. DevPro Biopharma is an industry leader in the development of respiratory products and is actively conducting studies in cystic fibrosis, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). DevPro’s expert team has collectively contributed to more than 50 approved products or label expansions.
American Thoracic Society
Founded in 1905, the American Thoracic Society is the world’s leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members in 133 countries are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care. Learn more at thoracic.org.
